4.3 Article

Loss of CCR2 expressing non-classical monocytes are associated with cognitive impairment in antiretroviral therapy-naive HIV-infected Thais

Journal

JOURNAL OF NEUROIMMUNOLOGY
Volume 288, Issue -, Pages 25-33

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2015.08.020

Keywords

HIV-associated neurocognitive disorders (HAND); Monocytes; C-C chemokine receptor (CCR) CCR2; CD163; Neopterin

Funding

  1. National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) [R01NS061696]
  2. NIH/NIMHD [U54MD007584, G12MD007601, P20GM103466]

Ask authors/readers for more resources

HIV DNA in monocytes has been linked to HIV-associated neurocognitive disorders (HAND), however, characterization of monocyte subsets associated with HAND remains unclear. We completed a prospective study of antiretroviral therapy-naive, MN-infected Thais, with varying degrees of cognitive impairment, compared to HIV-uninfected controls. Monocyte subsets' CCR2, CCR5 and CD163 expression were profiled and inflammatory markers in plasma and cerebrospinal fluid (CSF), measured. Lower numbers of CCR2(+) non-classical monocytes were associated with worse neuropsychological test performance (r = 0.43, p = 0.024). CCR2(+) non-classical monocyte count inversely correlated with CSF neopterin (r = 0.43, p = 0.035) and plasma TNF-alpha. levels (r = 0.40, p = 0.041). These data benchmark CCR2+non-classical monocytes as an independent index of cognitive impairment. (C) 2015 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available